CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11

European Journal of Immunology

Volumn 33, Issue 8, 2003, Pages 2241-2250

  Xanthou, Georgina ^a   Duchesnes, Cécile Emmanuelle ^a   Williams, Timothy John ^a   Pease, James Edward ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemokine; Inflammation; Leukocyte; Receptor

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR3; EOTAXIN; LIGAND;

BINDING SITE; CELL ACTIVITY; CHIMERA; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; REVIEW; TH1 CELL;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CELL SIZE; CHEMOKINES, CC; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; EPITOPES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LEUKOCYTES; LIGANDS; MICE; MODELS, IMMUNOLOGICAL; RECEPTORS, CHEMOKINE; TRANSFECTION;

EID: 0041474664     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323787     Document Type: Review

References (45)

1. Rossi, D. and Zlotnik, A., The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000. 18: 217-242.
2. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J. and Power, C. A., International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 2000. 52: 145-176.
3. Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A. and Sinigaglia, F., Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998. 187: 129-134.
4. Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C. and Dayer, J. M., CCR5 is characteristic of Th1 mphocytes. Nature 1998. 391: 344-345.
5. Sallusto, F., Lenig, D., Mackay, C. R. and Lanzavecchia, A., Flexible programs of chemokine receptor expression on human polarised T helper 1 and 2 lymphocytes. J. Exp. Med. 1998. 187: 875-883.
6. Inngjerdingen, M., Damaj, B. and Maghazachi, A. A., Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001. 97: 367-375.
7. Trentin, L., Agostini, C., Facco, M., Piazza, F., Perin, A., Siviero, M., Gurrieri, C., Galvan, S., Adami, F., Zambello, R. and Semenzato, G., The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J. Clin. Invest. 1999. 104: 115-121.
8. Luster, A. D. and Ravetch, J. V., Biochemical characterization of a gamma-interferon-inducible cytokine (tIP-10). J. Exp. Med. 1987. 166: 1084-1097.
9. Farber, J. M., A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA 1990. 87: 5238-5242.
10. Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., Sahagan, B. G. and Neote, K., Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998. 187: 2009-2021.
11. Balashov, K. E., Rottman, J. B., Weiner, H. L. and Hancock, W. W., CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 1999. 96: 6873-6878.
12. Liu, M. T., Chen, B. P., Oertel, P., Buchmeier, M. J., Armstrong, D., Hamilton, T. A. and Lane, T. E., The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 2000. 165: 2327-2330.
13. Reinhart, T. A., Fallert, B. A., Pfeifer, M. E., Sanghavi, S., Capuano, S., Rajakumar, P., Murphey-Corb, M., Day, R., Fuller, C. L. and Schaefer, T. M., Increased expression of the inflammatory chemokine CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome. Blood 2002. 99: 3119-3128.
14. Heath, H., Qin, S., Wu, L., LaRosa, G., Kassam, N., Ponath, P. D. and Mackay, C. R., Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 1997. 99: 178-184.
15. Uguccioni, M., Mackay, C. R., Ochensberger, B., Loetscher, P., Rhis, S., LaRosa, G. J., Rao, P., Ponath, P. D., Baggiolini, M. and Dahinden, C. A., High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest. 1997. 100: 1137-1143.
16. Ochi, H., Hirani, W. M., Yuan, Q., Friend, D. S., Austen, K. F. and Boyce, J. A., T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 1999. 190: 267-280.
17. Sallusto, F., Mackay, C. R. and Lanzavecchia, A., Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997. 277: 2005-2007.
18. Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J. and Williams, T. J., Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 1994. 179: 881-887.
19. Ponath, P. D., Qin, S., Ringler, D. J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J.-A., Newman, W., Gutierrez-Ramos, J.-C. and Mackay, C. R., Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 1996. 97: 604-612.
20. Patel, V. P., Kreider, B. L., Li, Y., Li, H., Leung, K., Salcedo, T., Nardelli, B., Pippalla, V., Gentz, S., Thotakura, R., Parmelee, D., Gentz, R. and Garotta, G., Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 1997. 185: 1163-1172.
21. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C. A., Langen, H., Thelen, M. and Baggiolini, M., Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 1997. 185: 2171-2176.
22. White, J. R., Imburgia, C., Dul, E. et al., Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Leukoc. Biol. 1997. 62: 667-675.
23. Kitaura, M., Suzuki, N., Imai, T., Takagi, S., Suzuki, R., Nakajima, T., Hirai, K., Nomiyama, H. and Yoshie, O., Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J. Biol. Chem. 1999. 274: 27975-27980.
24. Shinkai, A., Yoshisue, H., Koike, M., Shoji, E., Nakagawa, S., Saito, A., Takeda, T., Imabeppu, S., Kato, Y., Hanai, N., Anazawa, H., Kuga, T. and Nishi, T., A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. 1996. 163: 1602-1610.
25. Matthews, A. N., Friend, D. S., Zimmermann, N., Sarafi, M. N., Luster, A. D., Pearlman, E., Wert, S. E. and Rothenberg, M. E., Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 1998. 95: 6273-6278.
26. Berkman, N., Ohnona, S., Chung, F. K. and Breuer, R., Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am. J. Respir Cell Mol. Biol. 2001. 24: 682-687.
27. Dulkys, Y., Schramm, G., Kimmig, D., Knoss, S., Weyergraf, A., Kapp, A. and Eisner, J., Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J. Invest. Dermatol. 2001. 116: 498-505.
28. Weng, Y., Siciliano, S. J., Waldburger, K. E., Sirotina-Meisher, A., Staruch, M. J., Daugherty, B. L., Gould, S. L., Springer, M. S. and DeMartino, J. A., Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 1998. 273: 18288-18291.
29. Loetscher, P., Pellegrino, A., Gong, J. H., Mattioli, I., Loetscher, M., Bardi, G., Baggiolini, M. and Clark-Lewis, I., The ligands of CXC chemokine receptor 3, I-TAC, Mig and IP10, are natural antagonists for CCR3. J. Biol. Chem. 2001. 276: 2986-2991.
30. Sabroe, I., Hartnell, A., Jopling, L. A., Bel, S., Ponath, P. D., Pease, J. E., Collins, P. D. and Williams, T. J., Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol. 1999. 162: 2946-2955.
31. Sabroe, I., Peck, M. J., Jan Van Keulen, B., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J. and Pease, J. E., A small molecule antagonist of the chemokine receptors CCR1 and CCR3: Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry. J. Biol. Chem. 2000. 275: 25985-25992.
32. Bryan, S. A., Jose, P. J., Topping, J. R., Wilhelm, R., Soderberg, C., Kertesz, D., Barnes, P. J., Williams, T. J., Hansel, T. T. and Sabroe, I., Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Am. J. Respir. Crit. Care Med. 2002. 165: 1602-1609.
33. Pease, J. E., Wang, J., Ponath, P. D. and Murphy, P. M., The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1α and eotaxin binding, respectively, but a second domain is essential for receptor activation. J. Biol. Chem. 1998. 273: 19972-19976.
34. Cox, M. A., Jenh, C. H., Gonsiorek, W., Fine, J., Narula, S. K., Zavodny, P. J. and Hipkin, R. W., Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol. Pharmacol. 2001. 59: 707-715.
35. Ogilvie, P., Bardi, G., Clark-Lewis, I., Baggiolini, M. and Uguccioni, M., Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 2001. 97: 1920-1924.
36. Martinelli, R., Sabroe, I., LaRosa, G., Williams, T. J. and Pease, J. E., The CC chemokine eotaxin (CCL11) is a partial agonist of the chemokine receptor CCR2b. J. Biol. Chem. 2001. 276: 42957-42964.
37. Patel, D. D., Zachariah, J. P. and Whichard, L. P., CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin. Immunol. 2001. 98: 39-45.
38. Garcia-Lopez, M. A., Sanchez-Madrid, F., Rodriguez-Frade, J. M., Mellado, M., Acevedo, A., Garcia, M. I., Albar, J. P., Martinez, C. and Marazuela, M., CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab. Invest. 2001. 81: 409-418.
39. Dawson, T. C., Lentsch, A. B., Wang, Z., Cowhig, J. E., Rot, A., Maeda, N. and Peiper, S. C., Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000. 96: 1681-1684.
40. Mantovani, A., Locati, M., Vecchi, A., Sozzani, S. and Allavena, P., Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 2001. 22: 328-336.
41. Umland, S. P., Wan, Y., Shortall, J., Shah, H., Jakway, J., Garlisi, C. G., Tian, F., Egan, R. W. and Billah, M. M., Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells. J. Leukoc. Biol. 2000. 67: 441-447.
42. Elsner, J., Dulkys, Y., Kimmig, D., Wells, T. N., Proudfoot, A. E. and Kapp, A., Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils. Int. Arch. Allergy Immunol. 2001. 124: 227-229.
43. Monteclaro, F. S. and Charo, I. F., The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1α receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation. J. Biol. Chem. 1996. 271: 19084-19092.
44. Auger, G. A., Pease, J. E., Shen, X., Xanthou, G. and Barker, M. D., Alanine scanning mutagenesis of CCR3 reveals that the three intracellular loops are essential for functional receptor expression. Eur. J. Immunol. 2002. 32: 1052-1058.
45. Daugherty, B. L., Siciliano, S. J. and Springer, M. S., Radiolabeled chemokine binding assays. Methods Mol. Biol. 2000. 138: 129-134.